TABLE 2.
Primers used in this study.
| Name | Sequence (5’-3’) |
| int1 F | ATGGCAAATATCATTTTTTACCTAAGAGGCAC |
| int1 R | TTAGTTTAGTTGTTCAGGGGTAATGTTC |
| RAGI1 1F | GTATTTCCGTAGTCGCTTTGAGGATTCCTTCATCTTG |
| RAGI1 1R | TTTCATTTATTCAAAATGAGGGTTAAAATGAGTAAAAC |
| RAGI1 2F | CCACTTATCACAACGGTACTCTTAGCCAAATTAAAG |
| RAGI1 2R | CAATTTTCAGAATGGATAACAAAGGGGGTGTTTATA |
| RAint1 F | TCACGCGT TTTCATTTATTCAAAATGAGGGTTAAAATGAG |
| RAint1 R | GTGCATGC CTTAAAGTATTAGTTTAGTTGTTCAGGGGTAATGTTC |
| SpecR F | TGCGGTACC TATCAATCTACTGGACAGTAGTTTTAAAAG |
| SpecR R | TCACGCGT AAAACAACTTCAAAACAGTGGAACGAAAAC |
| Pspec R | CAGCTCCTCGCCCTTGCTCACCAT GATTTCACCTCGTTGATTATGTTCATATAA |
| eGFP F | GAACATAATCAACGAGGTGAAATC ATGGTGAGCAAGGGCGAGGAGCTGTTCACC |
| eGFP R | TCACGCGT TTACTTGTACAGCTCGTCCATGCCGAG |
The underline sequences indicated restriction sites.